Role of FDG-PET/CT in stage 1–4 malignant melanoma patients
Crossref DOI link: https://doi.org/10.1007/s00238-016-1228-0
Published Online: 2016-08-18
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Eldon, Mai http://orcid.org/0000-0002-5984-8001
Kjerkegaard, Ulrik Knap
Ørndrup, Mette Heisz
Sjøgren, Pia
Stolle, Lars Bjørn
Funding for this research was provided by:
No funding
License valid from 2016-08-18